Roivantsciences
Stock Plan Administrator
Roivant Sciences, Inc., 1 Pennsylvania Plaza, 54th floor, New York, NY 10119, United States. Posted 4 days ago
The role
This individual contributor will support US/Global equity operations by processing equity-related transactions and maintaining records. The role works under the direction of the Manager, Equity Administration to ensure accurate and timely transaction processing.
What you will do
- Process day-to-day stock administration transactions including grants, award terminations, equity vesting, options exercises, and ESPP enrollments
- Track grant agreement acceptances and follow up with employees
- Perform established SOX key control procedures and prepare supporting documentation
- Provide equity transaction data to Payroll for tax withholding and reporting
- Provide customer service to employees regarding equity questions
- Perform reconciliations of equity records between Stock Administration, HR and Payroll
- Run standard and ad hoc reports for reconciliations, audit, legal filings and tax
- Assist with special projects such as equity system improvements and automation
Required qualifications
- 3+ years of stock administration experience processing equity transactions
- BA/BS degree in relevant field
- Interest in pursuing ECA or CEP certification is a must
- Strong attention to detail and ability to perform self-audit
- Highly motivated with a desire to learn and grow in equity administration
- Problem solver with strong interpersonal, multi-tasking, and organizational skills
- Ability to meet deadlines
- Excellent verbal and written communication skills
- Quick learner who adapts well to a fast-moving environment
- Proficient in Microsoft Excel and PowerPoint
Nice to have
- Working knowledge of E*TRADE/Equity Edge Online
- Equity Compensation Associate (ECA) certification
Benefits
- Company-sponsored benefit programs
About the company
Roivant is a commercial-stage biopharmaceutical company that aims to improve the lives of patients by accelerating the development and commercialization of medicines. They advance their pipeline by creating nimble subsidiaries or “Vants” to develop and commercialize medicines and technologies.